L’Oreal Surpasses Q1 Expectations: Robust Growth in US and Europe Bolsters Sales Amid Market Concerns

L’Oreal Surpasses Q1 Expectations: Robust Growth in US and Europe Bolsters Sales Amid Market Concerns

THE WHAT? L’Oreal, the global leader in cosmetics, reported a robust 9.4% increase in first-quarter sales on a like-for-like basis, surpassing analyst expectations and alleviating concerns over potential slowdowns in its two largest markets, the United States and China. The company announced a total revenue of 11.24 billion euros ($11.98 billion) for the period ending March.

THE DETAILS  This performance exceeds the anticipated 6.1% rise forecasted by Jefferies analysts, with an 8.3% increase on a reported basis. Growth was particularly notable in North America and Europe, each up by over 12%, driven by robust sales in mass market products and dermatological lines. Despite broader market trepidations highlighted by a recent downturn in retailer Ulta Beauty’s outlook, L’Oreal’s consumer products division, including popular L’Oreal Paris and Elseve brands, grew by 11.1%. The dermatological segment, featuring brands like La Roche-Posay and CeraVe, saw a significant rise of 21.9%, fueled by ongoing medical endorsements.

THE WHY? Despite a challenging comparison base in travel retail and slower growth in mainland China, L’Oreal’s strategic focus on varied product lines has enabled it to maintain a leading position, especially in luxury beauty, where it holds a 34% market share in China. While the luxury division experienced modest growth of 1.8%, it still managed to surpass expectations and contribute to an overall positive quarter. L’Oreal’s resilience in adapting to market dynamics underscores its robust strategic framework, which continues to perform well against a backdrop of global economic uncertainty.

WELLNESS

FASHION

TRAVEL

PROFESSIONAL BEAUTY

JOBS & PEOPLE